Detalhe da pesquisa
1.
Phase I Trial Combining Chemokine-Targeting with Loco-Regional Chemoimmunotherapy for Recurrent, Platinum-Sensitive Ovarian Cancer Shows Induction of CXCR3 Ligands and Markers of Type 1 Immunity.
Clin Cancer Res
; 28(10): 2038-2049, 2022 05 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-35046055
2.
Multiple maternal proteins coordinate to restrict the translation of C. elegans nanos-2 to primordial germ cells.
Development
; 135(10): 1803-12, 2008 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-18417623